KPV Tripeptide (Lys-Pro-Val): C-Terminal Alpha-MSH Chemistry, NF-κB Inactivation, and Gut Mucosal Integrity
A biochemical review of the KPV tripeptide (Lys-Pro-Val). Transport via PepT1, nuclear translocation blockade of NF-κB p65, cytokine reduction (TNF-α, IL-6), and mucosal barrier restoration assays. KPV represents the C-terminal tripeptide (residues 11–13: Lys-Pro-Val) of the neurohormone alpha-melanocyte-stimulating hormone (alpha-MSH).
- KPV represents the C-terminal tripeptide (residues 11–13: Lys-Pro-Val) of the neurohormone alpha-melanocyte-stimulating hormone (alpha-MSH).
- Retains the full anti-inflammatory and mucosal restorative bioactivity of alpha-MSH without activating melanocortin MC1R pigmentary pathways.
- Internalized directly into intestinal epithelial cells and macrophages via the oligopeptide transporter PepT1 (SLC15A1).
- Directly inhibits IkappaB kinase (IKK) activation, preventing NF-kappaB p65 nuclear translocation and cytokine transcription.
| CAS Registry Number | 67727-97-3 |
|---|---|
| Molecular Formula | C16H30N4O4 |
| Molecular Mass | 342.44 g/mol |
| Primary Biological Target | Intestinal PepT1 Transporter, NF-κB Inactivation & IKK Phosphorylation |
| Analytical Purity Standard | ≥99.0% (RP-HPLC, C18, 214/220 nm) |
| Identity Verification | ESI-MS (±0.1 Da) + Karl Fischer Moisture (<3.0%) |
| Lyophilized Storage | -20°C desiccated, protected from UV light (24–36 months) |
| Reconstituted Storage | 2°C–8°C refrigerated (up to 28 days in 0.9% BA BAC water) |
1. Sequence Origin: The Anti-Inflammatory Core of Alpha-MSH
Alpha-Melanocyte-Stimulating Hormone (alpha-MSH) is a 13-amino-acid tridecapeptide produced by the pro-opiomelanocortin (POMC) gene with potent anti-inflammatory and immunomodulatory properties. Structure-activity relationship (SAR) studies demonstrated that the C-terminal tripeptide sequence, H-Lys-Pro-Val-OH (KPV, MW 342.44 g/mol), contains the entire anti-inflammatory pharmacophore of alpha-MSH while omitting the central His-Phe-Arg-Trp core responsible for melanocortin receptor (MC1R) pigmentation.
2. Transport Kinetics via the PepT1 Transporter
Unlike larger oligopeptides that require endocytosis or extracellular enzymatic breakdown, KPV is a direct substrate for the proton-coupled oligopeptide transporter 1 (PepT1 / SLC15A1). PepT1 is densely expressed on the apical brush-border membrane of intestinal epithelial cells (enterocytes) and is upregulated in inflamed mucosal tissue, providing high cellular uptake and intracellular bioavailability.
3. Molecular Inactivation of the NF-κB Pathway
Upon intracellular entry, KPV exerts anti-inflammatory actions by inhibiting the IkappaB kinase (IKK) complex. This preserves cytoplasmic IkappaB-alpha levels and prevents the phosphorylation and nuclear translocation of the NF-kappaB p65 (RelA) transcription factor. As a direct consequence, downstream transcription of pro-inflammatory cytokines (including TNF-alpha, IL-1beta, IL-6, and IL-8) and inducible nitric oxide synthase (iNOS) is suppressed in vitro by over 70%.
4. Laboratory Solubility and Handling
KPV is a white, crystalline, hydrophilic tripeptide that dissolves readily in sterile water, Bacteriostatic Water, and physiological saline at concentrations up to 50 mg/mL. The compound should be kept desiccated at -20°C. Reconstituted solutions are highly stable at 2°C to 8°C for 30 days.
5. Bench Preparation & Assay Reproducibility for KPV Tripeptide (Lys-Pro-Val)
When designing in-vitro experiments targeting Intestinal PepT1 Transporter, NF-κB Inactivation & IKK Phosphorylation, normalize dosing across replicates by molar concentration (µM or nM) using the published molecular weight (342.44 g/mol) and batch counterion composition rather than gross powder weight alone. Log lot numbers, diluent pH, and aliquot dates to ensure batch-to-batch reproducibility across longitudinal experiments.
Peer-Reviewed References & Analytical Standards
- Kannengiesser K. et al. (2008). Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases, 14(3), 324–331. [PMID: 18092346 ↗]
- Dalmasso G. et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. [PMID: 18061177 ↗]
Referenced Laboratory Research Reagents
Batch-verified SwissLab catalog entries cited in this monograph
All analytical monographs and chemical data are published strictly for in-vitro laboratory research and scientific reference. Reagents must be handled by qualified personnel wearing appropriate PPE. Not for human or veterinary use.